Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Joseph Yang
Institution:
Boehringer Ingelheim (United States)
Observed institution:
Boehringer Ingelheim (United States)
ORCID:
0009-0001-1874-8880
Observed ORCID:
0009-0001-1874-8880
OpenAlex ID:
A5127049908
Real-World Health Care Resource Utilization and Economic Burden Among Patients with Idiopathic Pulmonary Fibrosis in Commercially Insured and Medicare Advantage Populations in the United States
2026
·
Joseph Yang
, Rebecca Fee
, et al.
·
Journal of health economics and outcomes research
Real-World Economic Burden Associated with Progressive Pulmonary Fibrosis in the US: An Administrative Claims Database Analysis
2026
·
Joseph Yang
, Bonnie H. Bui
, et al.
·
PharmacoEconomics
PDF
Post-progression treatment patterns in systemic autoimmune rheumatic disease-associated interstitial lung disease: insights from a US retrospective, observational study
2026
·
Joseph Yang
, Katy Sadowski
, et al.
·
BMJ Open
PDF
Health care utilization and costs associated with acute exacerbation of fibrosing interstitial lung disease in the United States: A retrospective administrative claims database analysis
2026
·
Joseph Yang
, Katy Sadowski
, et al.
·
Journal of Managed Care & Specialty Pharmacy
Show more works
View as search
Works count:
4
Citation count:
H-index:
I10-index:
Year
Topic
Type